Contamination introduced during mixing accelerates degradation and creates safety risks
D., Correa, M., Mingote, S
The safety pillar earns a B rather than an A primarily because of the pharmacy network: six compounding partners are named in the terms of service, and multiple carry documented regulatory records that remain at least partially unresolved
8.5 Geriatric Use Of the total number of patients (n=1,375) treated with NOVOLOG in 3 controlled clinical studies, 2.6% (n=36) were 65 years of age or over
Novo Nordisk's patent protection prevents other manufacturers from producing bioequivalent generic copies until the late 2020s or early 2030s
Importantly, even reducing heavy drinking can lead to meaningful improvements for patients and families. Researchers recruited 50 adults, all of them already seeking help for moderate-to-severe AUD